Cancer Family
Solid Neoplasm
CI-CAN-00000052Explore in graph →
Non-malignant1,823 active trials28 evidence items
- NCIt
- C9292
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000052Explore in graph →
Clinical trials
6,089 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00667147 | Phase I Abraxane Weekly and Three Weekly Schedule With Vandetanib | completed | Phase 1 | 65 | University of Southern CaliforniaOTHER | 1 | Nov 19, 2014 | clinicaltrials |
| NCT01165385 | Study With Pazopanib in Combination With Cisplatin (CDDP) in Patients With Advanced Solid Tumors(PACIFIK) | completed | Phase 1 | 35 | UNICANCEROTHER | 1 | Nov 17, 2014 | clinicaltrials |
| NCT01238939 | Study of NK012 and 5-FU/LV in Solid Tumors Followed by Dose Expansion in Colorectal Cancer | completed | Phase 1 | 35 | Nippon Kayaku Co., Ltd.INDUSTRY | 1 | Nov 13, 2014 | clinicaltrials |
| NCT01238952 | Study of NK012 and Carboplatin in Solid Tumors With Dose Expansion in Triple Negative Breast Cancer | completed | Phase 1 | 4 | Nippon Kayaku Co., Ltd.INDUSTRY | 1 | Nov 13, 2014 | clinicaltrials |
| NCT01158274 | RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 2 | Nov 7, 2014 | clinicaltrials |
| NCT00695032 | Kidney Damage in Patients Receiving Cisplatin and Ifosfamide for Solid Tumors | suspended | N/A | 80 | Institut Claudius RegaudOTHER | 1 | Nov 5, 2014 | clinicaltrials |
| NCT01088763 | Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia | terminated | Phase 1 | 129 | National Cancer Institute (NCI)NIH | 2 | Nov 5, 2014 | clinicaltrials |
| NCT02033148 | Icotinib Hydrochloride in Treating Patients With Advanced Cancers | withdrawn | Phase 1 | 0 | Roswell Park Cancer InstituteOTHER | 0 | Nov 5, 2014 | clinicaltrials |
| NCT00914914 | Safety Study of a Cell Penetrating Peptide (p28) to Treat Solid Tumors That Resist Standard Methods of Treatment | completed | Phase 1 | 15 | Dr. Tapas K. Das GuptaINDUSTRY | 1 | Oct 28, 2014 | clinicaltrials |
| NCT01164163 | INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease | completed | Phase 1 | 49 | Children's Oncology GroupNETWORK | 1 | Oct 23, 2014 | clinicaltrials |
| NCT01245205 | Akt Inhibitor MK2206 in Combination With Lapatinib Ditosylate in Patients With Advanced or Metastatic Solid Tumors or Breast Cancer | completed | Phase 1 | 28 | National Cancer Institute (NCI)NIH | 1 | Oct 23, 2014 | clinicaltrials |
| NCT01567163 | A Study of Ramucirumab and Docetaxel in Participants With Solid Tumors | completed | Phase 2 | 22 | Eli Lilly and CompanyINDUSTRY | 1 | Oct 16, 2014 | clinicaltrials |
| NCT01919866 | Safety Study of CD3/CD19 Depleted Haploidentical Stem Cells | unknown | Phase 1 / Phase 2 | 120 | University Children's Hospital TuebingenOTHER | 2 | Oct 8, 2014 | clinicaltrials |
| NCT02255292 | A Study: Pure CBD as Single-agent for Solid Tumor. | unknown | Phase 2 | 60 | Hadassah Medical OrganizationOTHER | 0 | Oct 2, 2014 | clinicaltrials |
| NCT00357500 | Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive Cancer | completed | Phase 2 | 101 | Dana-Farber Cancer InstituteOTHER | 1 | Oct 1, 2014 | clinicaltrials |
| NCT00910039 | Sunitinib Malate After Stereotactic Radiosurgery in Treating Patients With Newly Diagnosed Brain Metastases | terminated | Phase 2 | 14 | Case Comprehensive Cancer CenterOTHER | 1 | Sep 29, 2014 | clinicaltrials |
| NCT01762410 | Clinical Study of Oral PI3K/mTOR Inhibitor in Patients With Advanced Refractory Solid Tumors | suspended | Phase 1 | 60 | Piramal Enterprises LimitedINDUSTRY | 2 | Sep 29, 2014 | clinicaltrials |
| NCT01779336 | Clinical Study of Oral IGF-1R Inhibitor in Subjects With Advanced Refractory Solid Tumors | suspended | Phase 1 | 70 | Piramal Enterprises LimitedINDUSTRY | 2 | Sep 29, 2014 | clinicaltrials |
| NCT01835184 | Cabozantinib-S-Malate and Vemurafenib in Treating Patients With Solid Tumors or Melanoma That is Metastatic or That Cannot Be Removed By Surgery | terminated | Phase 1 | 5 | National Cancer Institute (NCI)NIH | 1 | Sep 25, 2014 | clinicaltrials |
| NCT01992341 | AMG 386 Drug-Drug Interaction Study With Paclitaxel | completed | Phase 1 | 35 | AmgenINDUSTRY | 1 | Sep 23, 2014 | clinicaltrials |
| NCT00968916 | Dose Escalation, Safety and Pharmacokinetic Study of AVE8062 in Patients With Solid Tumors | completed | Phase 1 | 15 | SanofiINDUSTRY | 1 | Sep 19, 2014 | clinicaltrials |
| NCT01279603 | Study of GO-203-2C Given Intravenously in Patients With Advanced Solid Tumors Including Lymphomas | completed | Phase 1 | 23 | Genus Oncology, LLCINDUSTRY | 1 | Sep 19, 2014 | clinicaltrials |
| NCT00687934 | Study of STA-9090, Administered Once-Weekly in Patients With Solid Tumors | completed | Phase 1 | 53 | Synta Pharmaceuticals Corp.INDUSTRY | 1 | Sep 18, 2014 | clinicaltrials |
| NCT00688116 | Study of STA-9090, Administered Twice-Weekly in Patients With Solid Tumors | unknown | Phase 1 | 45 | Synta Pharmaceuticals Corp.INDUSTRY | 1 | Sep 18, 2014 | clinicaltrials |
| NCT00004258 | EMD 121974 in Treating Patients With Locally Advanced or Metastatic Cancer | completed | Phase 1 | 40 | Indiana UniversityOTHER | 1 | Sep 17, 2014 | clinicaltrials |
| NCT01702129 | Anti-EGFR Immunoliposomes in Solid Tumors | completed | Phase 1 | 26 | University Hospital, Basel, SwitzerlandOTHER | 1 | Sep 9, 2014 | clinicaltrials |
| NCT00057915 | Vaccine Therapy in Treating Patients With Refractory Stage IV Cancer | completed | Phase 1 | 4 | Duke UniversityOTHER | 1 | Sep 8, 2014 | clinicaltrials |
| NCT00275080 | Vorinostat and Decitabine in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Non-Hodgkin's Lymphoma, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Chronic Myelogenous Leukemia | completed | Phase 1 | 80 | National Cancer Institute (NCI)NIH | 1 | Aug 27, 2014 | clinicaltrials |
| NCT01994031 | Dose Escalation and Pharmacokinetic Study of Paclitaxel Liposome Injection in Treating Patients With Advanced Solid Tumor After Failure From Conventional Treatments | unknown | Phase 4 | 36 | Nanjing Luye Sike Pharmaceutical Co., Ltd.INDUSTRY | 1 | Aug 27, 2014 | clinicaltrials |
| NCT02213822 | Molecular Testing of Cancer by Integrated Genomic, Transcriptomic, and Proteomic Analysis | unknown | — | 500 | Rhode Island HospitalOTHER | 1 | Aug 27, 2014 | clinicaltrials |
| NCT00720148 | A Phase I Trial of Bortezomib and Sunitinib | completed | Phase 1 | 30 | Emory UniversityOTHER | 1 | Aug 26, 2014 | clinicaltrials |
| NCT01008930 | Feasibility Study for Imaging of Peripheral Tumors With a High-Resolution PET Imaging System | completed | N/A | 19 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 20, 2014 | clinicaltrials |
| NCT01392976 | Safety and Pharmacokinetic Profiles of Two Formulations of CO-1.01 in Patients With Advanced Solid Tumors | completed | Phase 1 | 17 | Clovis Oncology, Inc.INDUSTRY | 1 | Aug 15, 2014 | clinicaltrials |
| NCT01313065 | Evaluation of Safety, Tolerability, PK & PD of Intravenous VX15/2503 in Patients With Advanced Solid Tumors | completed | Phase 1 | 42 | Vaccinex Inc.INDUSTRY | 1 | Aug 13, 2014 | clinicaltrials |
| NCT01974349 | To Assess the Effect of Food on the Pharmacokinetics of Selumetinib (AZD6244; ARRY-142886) (Hyd-Sulfate) in Healthy Male Volunteers | completed | Phase 1 | 39 | AstraZenecaINDUSTRY | 1 | Aug 13, 2014 | clinicaltrials |
| NCT00003750 | Biological Therapy in Treating Children With Refractory or Recurrent Neuroblastoma or Other Tumors | completed | Phase 1 | 28 | Children's Oncology GroupNETWORK | 3 | Aug 8, 2014 | clinicaltrials |
| NCT00458744 | Talotrexin in Treating Young Patients With Recurrent Solid Tumors or Leukemia That is Recurrent or Does Not Respond to Treatment | withdrawn | Phase 1 | 0 | Children's Oncology GroupNETWORK | 0 | Aug 8, 2014 | clinicaltrials |
| NCT01215864 | Study of Intravenous TCD-717 in Patients With Advanced Solid Tumors | completed | Phase 1 | 28 | Traslational Cancer Drugs Pharma, SLINDUSTRY | 1 | Aug 8, 2014 | clinicaltrials |
| NCT00107458 | Valproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS Tumors | completed | Phase 1 | 26 | Children's Oncology GroupNETWORK | 2 | Aug 7, 2014 | clinicaltrials |
| NCT00003070 | Enalapril in Treating Heart Damage Patients Who Received Anthracycline Chemotherapy for Childhood Cancer | completed | Phase 3 | 13 | Children's Oncology GroupNETWORK | 3 | Aug 5, 2014 | clinicaltrials |
| NCT00429702 | Diphenhydramine, Lorazepam, and Dexamethasone in Treating Nausea and Vomiting Caused By Chemotherapy | terminated | Phase 2 | 7 | University of South FloridaOTHER | 2 | Jul 25, 2014 | clinicaltrials |
| NCT00002621 | Interferon Alfa in Treating Children With HIV-Related Cancer | completed | Phase 2 | 8 | Children's Oncology GroupNETWORK | 4 | Jul 24, 2014 | clinicaltrials |
| NCT00567931 | 1-Methyl-D-Tryptophan in Treating Patients With Metastatic or Refractory Solid Tumors That Cannot Be Removed By Surgery | completed | Phase 1 | 52 | National Cancer Institute (NCI)NIH | 1 | Jul 24, 2014 | clinicaltrials |
| NCT01191216 | 1-Methyl-D-Tryptophan and Docetaxel in Treating Patients With Metastatic Solid Tumors | completed | Phase 1 | 27 | National Cancer Institute (NCI)NIH | 1 | Jul 24, 2014 | clinicaltrials |
| NCT00847054 | A Study of of MORAb-004 in Subjects With Solid Tumors | completed | Phase 1 | 80 | MorphotekINDUSTRY | 1 | Jul 16, 2014 | clinicaltrials |
| NCT00909207 | Patient-Reported Outcomes Version of Common Terminology Criteria (CTCPRO) Cognitive Debriefing | completed | — | 20 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 14, 2014 | clinicaltrials |
| NCT00002948 | High-Dose Topotecan and Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer | terminated | Phase 1 | — | Yale UniversityOTHER | 1 | Jul 2, 2014 | clinicaltrials |
| NCT00759928 | PK Trial of Sorafenib & Erlotinib in Patients With Refractory Solid Tumors | completed | Phase 1 | 48 | SCRI Development Innovations, LLCOTHER | 1 | Jul 2, 2014 | clinicaltrials |
| NCT01222546 | Study of CH5132799 Administered Orally in Patients With Advanced Solid Tumors | completed | Phase 1 | 38 | Chugai Pharma Europe Ltd.INDUSTRY | 1 | Jun 23, 2014 | clinicaltrials |
| NCT00408655 | Temsirolimus, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 38 | National Cancer Institute (NCI)NIH | 1 | Jun 19, 2014 | clinicaltrials |
Data updated 23 days agoSource updated Nov 19, 2014source: clinicaltrials